找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

1234
返 回
新窗
投票 ESCI期刊Drug Target Insights 2024/2025影响因子:2.174 (DRUG TARGET INSIGHT) (1177-3928). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emer  ...234
Total Citations:228; 2023 JIF:2.174; JIFRank: 222/354 ; Rank-JIF: 222; Number-of-JIF:354; 5 Year JIF:2.498; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.9; Immediacy Index:0.6; Immediacy Index-dealt:0.632; 2023 JCI:0.39; JCI Rank: 273/354 ; Total Articles:9; JCI Quartile:Q4; JCI Percentile:23.02; Eigenfactor:0; Normalized Eigenfactor:0.023; Article Influence Score:0.467; JIF Percentile:37.4; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:13; % of Articles in Citable items:0.6923; Cited Half-Life:10.1; Citing Half-Life:6.9; % of OA Gold:0.931; Publisher name:MDPI; Publisher address:ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052;
投票 ESCI期刊Turkish Journal of Pharmaceutical Sciences 2024/2025影响因子:1.816 (TURK J PHARM SCI) (1304-530X). (PHARMACOLOGY & PH  ...234
Total Citations:1022; 2023 JIF:1.816; JIFRank: 240/354 ; Rank-JIF: 240; Number-of-JIF:354; 5 Year JIF:1.955; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.4; Immediacy Index-dealt:0.495; 2023 JCI:0.47; JCI Rank: 250/354 ; Total Articles:46; JCI Quartile:Q3; JCI Percentile:29.52; Eigenfactor:0.001; Normalized Eigenfactor:0.187; Article Influence Score:0.258; JIF Percentile:32.3; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:49; % of Articles in Citable items:0.9388; Cited Half-Life:3.9; Citing Half-Life:8.9; % of OA Gold:1; Publisher name:GAIDAR INST ECONOMIC POLICY; Publisher address:GAZETNYI PER, 5, MOSCOW, RUSSIA,
投票 ESCI期刊Future Journal of Pharmaceutical Sciences 2024/2025影响因子:3.46 (FUTUR J PHARM SCI) (2314-7245). (PHARMACOLOGY & PHA  ...234
Total Citations:1871; 2023 JIF:3.46; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:3.522; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.4; Immediacy Index:0.5; Immediacy Index-dealt:0.552; 2023 JCI:0.65; JCI Rank: 177/354 ; Total Articles:96; JCI Quartile:Q2; JCI Percentile:50.14; Eigenfactor:0.002; Normalized Eigenfactor:0.278; Article Influence Score:0.421; JIF Percentile:70.5; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:121; % of Articles in Citable items:0.7934; Cited Half-Life:2.8; Citing Half-Life:7.8; % of OA Gold:0.9952; Publisher name:ACADEMIC PRESS INC ELSEVIER SCIENCE; Publisher address:525 B ST, STE 1900,
投票 ESCI期刊Journal of Young Pharmacists 2024/2025影响因子:0.486 (J YOUNG PHARM) (0975-1483). (PHARMACOLOGY & PHARMACY)(药理学与药学)Em  ...234
Total Citations:910; 2023 JIF:0.486; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.697; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:0.1; Immediacy Index-dealt:0.148; 2023 JCI:0.1; JCI Rank: 341/354 ; Total Articles:72; JCI Quartile:Q4; JCI Percentile:3.81; Eigenfactor:0; Normalized Eigenfactor:0.073; Article Influence Score:0.078; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:87; % of Articles in Citable items:0.8276; Cited Half-Life:8.8; Citing Half-Life:8.4; % of OA Gold:0.871; Publisher name:INT JOURNAL PARTICLE THERAPY; Publisher address:2000 SW ARCHER RD, GAINESVILLE, Unit
投票 ESCI期刊Drugs-Real World Outcomes 2024/2025影响因子:1.937 (DRUGS-REAL WOR OUTC) (2199-1154). (PHARMACOLOGY & PHARMACY)(药理学与药学  ...234
Total Citations:532; 2023 JIF:1.937; JIFRank: 231/354 ; Rank-JIF: 231; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:1.8; Immediacy Index:0.3; Immediacy Index-dealt:0.351; 2023 JCI:0.58; JCI Rank: 207/354 ; Total Articles:59; JCI Quartile:Q3; JCI Percentile:41.67; Eigenfactor:0.001; Normalized Eigenfactor:0.095; Article Influence Score:0.133; JIF Percentile:34.9; JIF Quartile:Q3; AIS Quartile:NULL; Citable Items:60; % of Articles in Citable items:0.9833; Cited Half-Life:3.1; Citing Half-Life:6.8; % of OA Gold:1; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 ESCI期刊Istanbul Journal of Pharmacy 2024/2025影响因子:0.586 (ISTANB J PHARM) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emergi  ...234
Total Citations:161; 2023 JIF:0.586; JIFRank: 331/354 ; Rank-JIF: 331; Number-of-JIF:354; 5 Year JIF:0.617; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.5; Immediacy Index:<0.1; Immediacy Index-dealt:0.014; 2023 JCI:0.13; JCI Rank: 332/354 ; Total Articles:44; JCI Quartile:Q4; JCI Percentile:6.36; Eigenfactor:0; Normalized Eigenfactor:0.033; Article Influence Score:0.093; JIF Percentile:6.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:48; % of Articles in Citable items:0.9167; Cited Half-Life:3.8; Citing Half-Life:10.3; % of OA Gold:0.4539; Publisher name:ELSEVIER IRELAND LTD; Publisher address:ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PA
投票 ESCI期刊Reviews on Recent Clinical Trials 2024/2025影响因子:1.468 (REV RECENT CLIN TRIA) (1574-8871). (PHARMACOLOGY & PHARMAC  ...234
Total Citations:592; 2023 JIF:1.468; JIFRank: 275/354 ; Rank-JIF: 275; Number-of-JIF:354; 5 Year JIF:1.552; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.3; Immediacy Index:0.5; Immediacy Index-dealt:0.518; 2023 JCI:0.36; JCI Rank: 278/354 ; Total Articles:23; JCI Quartile:Q4; JCI Percentile:21.61; Eigenfactor:0.001; Normalized Eigenfactor:0.123; Article Influence Score:0.346; JIF Percentile:22.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:34; % of Articles in Citable items:0.6765; Cited Half-Life:5.9; Citing Half-Life:6.8; % of OA Gold:0.0244; Publisher name:SPRINGER; Publisher address:VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS,
投票 ESCI期刊Advances in Pharmacology and Pharmacy 2024/2025影响因子:0.445 (ADV PHARMACOL PHARM) (2332-0036). (PHARMACOLOGY & PHAR  ...234
Total Citations:77; 2023 JIF:0.445; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.515; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.5; Immediacy Index-dealt:0.599; 2023 JCI:0.11; JCI Rank: 337/354 ; Total Articles:27; JCI Quartile:Q4; JCI Percentile:4.94; Eigenfactor:0; Normalized Eigenfactor:0.008; Article Influence Score:0.058; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:31; % of Articles in Citable items:0.871; Cited Half-Life:NULL; Citing Half-Life:10.4; % of OA Gold:1; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 ESCI期刊FARMACIA HOSPITALARIA 2024/2025影响因子:1.179 (FARM HOSP) (1130-6343). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging Sour  ...234
Total Citations:529; 2023 JIF:1.179; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:1.325; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:0.1; Immediacy Index-dealt:0.191; 2023 JCI:0.32; JCI Rank: 290/354 ; Total Articles:71; JCI Quartile:Q4; JCI Percentile:18.22; Eigenfactor:0.001; Normalized Eigenfactor:0.118; Article Influence Score:0.289; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:85; % of Articles in Citable items:0.8353; Cited Half-Life:4.9; Citing Half-Life:6.7; % of OA Gold:0.3979; Publisher name:HERPETOLOGICAL SOC JAPAN, KYOTO UNIV, GRADUATE SCH SCIE; Publisher address:D
投票 ESCI期刊Research Journal of Pharmacognosy 2024/2025影响因子:1.108 (RES J PHARMACOGN) (2345-4458). (PHARMACOLOGY & PHARMACY)(药  ...234
Total Citations:436; 2023 JIF:1.108; JIFRank: 296/354 ; Rank-JIF: 296; Number-of-JIF:354; 5 Year JIF:1.195; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.2; Immediacy Index-dealt:0.224; 2023 JCI:0.25; JCI Rank: 303/354 ; Total Articles:29; JCI Quartile:Q4; JCI Percentile:14.55; Eigenfactor:0; Normalized Eigenfactor:0.05; Article Influence Score:0.142; JIF Percentile:16.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:35; % of Articles in Citable items:0.8286; Cited Half-Life:6; Citing Half-Life:7.3; % of OA Gold:0; Publisher name:BMJ PUBLISHING GROUP; Publisher address:BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON,
投票 ESCI期刊Pharmacy Practice-Granada 2024/2025影响因子:2.482 (PHARM PRACT-GRANADA) (1885-642X). (PHARMACOLOGY & PHARMACY)(药理学与药学  ...234
Total Citations:1440; 2023 JIF:2.482; JIFRank: 188/354 ; Rank-JIF: 188; Number-of-JIF:354; 5 Year JIF:2.564; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.3; Immediacy Index:0.2; Immediacy Index-dealt:0.259; 2023 JCI:0.65; JCI Rank: 177/354 ; Total Articles:77; JCI Quartile:Q2; JCI Percentile:50.14; Eigenfactor:0.001; Normalized Eigenfactor:0.316; Article Influence Score:0.517; JIF Percentile:47; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:85; % of Articles in Citable items:0.9059; Cited Half-Life:4.9; Citing Half-Life:6.9; % of OA Gold:0.9913; Publisher name:GEMMOLOGICAL ASSOC GREAT BRITAIN; Publisher address:21 ELY PLACE, LONDON, ENG
投票 ESCI期刊DRUGS & THERAPY PERSPECTIVES 2024/2025影响因子:0.694 (DRUGS THER PERSPECT) (1172-0360). (PHARMACOLOGY & PHARMACY)(药理学  ...234
Total Citations:295; 2023 JIF:0.694; JIFRank: 326/354 ; Rank-JIF: 326; Number-of-JIF:354; 5 Year JIF:0.644; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.1; Immediacy Index-dealt:0.131; 2023 JCI:0.23; JCI Rank: 307/354 ; Total Articles:43; JCI Quartile:Q4; JCI Percentile:13.42; Eigenfactor:0; Normalized Eigenfactor:0.095; Article Influence Score:0.133; JIF Percentile:8.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:49; % of Articles in Citable items:0.8776; Cited Half-Life:3.5; Citing Half-Life:4.1; % of OA Gold:0.1173; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 ESCI期刊Advances in Traditional Medicine 2024/2025影响因子:1.853 (ADV TRADIT MED) (2662-4052). (PHARMACOLOGY & PHARMACY)(药理学与  ...234
Total Citations:564; 2023 JIF:1.853; JIFRank: 240/354 ; Rank-JIF: 240; Number-of-JIF:354; 5 Year JIF:1.793; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.2; Immediacy Index-dealt:0.283; 2023 JCI:0.4; JCI Rank: 270/354 ; Total Articles:35; JCI Quartile:Q4; JCI Percentile:23.87; Eigenfactor:0.001; Normalized Eigenfactor:0.117; Article Influence Score:0.226; JIF Percentile:32.3; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:52; % of Articles in Citable items:0.6731; Cited Half-Life:3; Citing Half-Life:8.5; % of OA Gold:0.049; Publisher name:SAGE PUBLICATIONS INC; Publisher address:2455 TELLER RD, THOUSAND OAKS, USA, CA,
投票 ESCI期刊Drug Discoveries and Therapeutics 2024/2025影响因子:1.937 (DRUG DISCOV THER) (1881-7831). (PHARMACOLOGY & PHARMACY)(药  ...234
Total Citations:1088; 2023 JIF:1.937; JIFRank: 231/354 ; Rank-JIF: 231; Number-of-JIF:354; 5 Year JIF:1.867; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.7; Immediacy Index:0.2; Immediacy Index-dealt:0.257; 2023 JCI:0.93; JCI Rank: 95/354 ; Total Articles:53; JCI Quartile:Q2; JCI Percentile:73.31; Eigenfactor:0.001; Normalized Eigenfactor:0.178; Article Influence Score:0.356; JIF Percentile:34.9; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:64; % of Articles in Citable items:0.8281; Cited Half-Life:6.5; Citing Half-Life:7; % of OA Gold:0.9451; Publisher name:CAMBRIDGE UNIV PRESS; Publisher address:EDINBURGH BLDG, SHAFTESBURY RD, CAMBRI
投票 ESCI期刊Journal of Pharmaceutical Policy and Practice 2024/2025影响因子:3.391 (J PHARM POLICY PRACT) (NULL). (PHARMACOLOGY &  ...234
Total Citations:1370; 2023 JIF:3.391; JIFRank: 118/354 ; Rank-JIF: 118; Number-of-JIF:354; 5 Year JIF:3.772; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3; Immediacy Index:0.6; Immediacy Index-dealt:0.624; 2023 JCI:0.96; JCI Rank: 91/354 ; Total Articles:143; JCI Quartile:Q2; JCI Percentile:74.44; Eigenfactor:0.002; Normalized Eigenfactor:0.442; Article Influence Score:0.835; JIF Percentile:66.8; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:163; % of Articles in Citable items:0.8773; Cited Half-Life:3; Citing Half-Life:6; % of OA Gold:1; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊ACS Pharmacology & Translational Science 2024/2025影响因子:4.957 (ACS PHARMACOL TRANSL) (NULL). (PHARMACOLOGY & PHARM  ...234
Total Citations:2411; 2023 JIF:4.957; JIFRank: 45/354 ; Rank-JIF: 45; Number-of-JIF:354; 5 Year JIF:4.925; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.9; Immediacy Index:0.9; Immediacy Index-dealt:0.993; 2023 JCI:1.42; JCI Rank: 30/354 ; Total Articles:123; JCI Quartile:Q1; JCI Percentile:91.67; Eigenfactor:0.005; Normalized Eigenfactor:NULL; Article Influence Score:NULL; JIF Percentile:87.4; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:153; % of Articles in Citable items:0.8039; Cited Half-Life:2.6; Citing Half-Life:7.7; % of OA Gold:0.1782; Publisher name:ASSOC COMPUTING MACHINERY; Publisher address:1601 Broadway, 10th Floor, NEW YO
投票 ESCI期刊Current Reviews in Clinical and Experimental Pharmacology 2024/2025影响因子:1.329 (CURR REV CLIN EXP PH) (2772-4328).  ...234
Total Citations:107; 2023 JIF:1.329; JIFRank: 283/354 ; Rank-JIF: 283; Number-of-JIF:354; 5 Year JIF:1.337; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.3; Immediacy Index:1; Immediacy Index-dealt:1.183; 2023 JCI:0.41; JCI Rank: 267/354 ; Total Articles:3; JCI Quartile:Q4; JCI Percentile:24.72; Eigenfactor:0; Normalized Eigenfactor:0.032; Article Influence Score:0.269; JIF Percentile:20.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:22; % of Articles in Citable items:0.1364; Cited Half-Life:1.8; Citing Half-Life:11; % of OA Gold:0.0455; Publisher name:NULL; Publisher address:NULL;
下一页 »
1234
返 回
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-8 17:10
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块